XELJANZ tofacitiinib (as citrate) 1mg/mL oral solution bottle

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4fe38ef05c04dd0c
Product Name: XELJANZ tofacitiinib (as citrate) 1mg/mL oral solution bottle
Artg Id: 386772
Artg Name: XELJANZ tofacitinib (as citrate) 1mg/mL oral solution bottle
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2023-01-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/130bfdd9bb5bb5bbd0c1128f4972b288.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8d624dad1431817fb281b032dc7acea4.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

4fe38ef05c04dd0c

Type

Standard